A rush of vaccines, virus tests and a busy flu season started overwhelming pharmacies more than a year ago, forcing many to temporarily close when workers weren't available.
Pfizer executives said the U.S. commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots.